Refractory angina pectoris: To transplant or not to transplant, that is the question

Authors

Keywords:

Angina Pectoris, Coronary Artery Bypass, Endarterectomy, Heart Transplantation, Heart-Assist Devices

Abstract

Heart transplantation is the treatment of choice for many patients with end-stage heart failure (HF) who remain symptomatic even under optimal medical therapy. Although ischemic cardiomyopathy is among the main etiologies that generate the indication for heart transplantation, patients with obstructive coronary artery disease without ventricular dysfunction are not commonly referred to heart transplantation programs. Some of these patients, however, are considered by national and international guidelines as potential candidates for heart transplantation if they present with refractory angina pectoris without the possibility of myocardial revascularization. The definition of clinical refractoriness and technical feasibility for myocardial revascularization, in addition to the risks involved for the different care strategies, are not common to all services that deal with patients with severe cardiovascular diseases and heart transplantation. This report aims to discuss the case of a 42-year-old male patient with severe obstructive coronary artery disease and complex coronary anatomy, with refractory angina pectoris, referred to the heart transplant program for a combined heart-kidney transplant (patient with renal failure on dialysis and other severe comorbidities), whose care was defined and performed in a multidisciplinary manner. The patient was prepared for a high-risk cardiac intervention and had an excellent evolution after coronary artery bypass grafting with the new technique of extensive endarterectomy, under direct vision and reconstruction of the anterior descending artery. Devices for back-up mechanical circulatory support in the perioperative period and preoperative assessment for heart transplantation were part of the individualized care strategy that, fortunately, were not used. At this time, the patient is in preparation for isolated kidney transplantation. Structured, multidisciplinary care programs matured in quality and safety processes can offer care alternatives aligned with the patient's values ​​and preferences, aiming to improve the quality of life and the individual's perspective of life and guarantee the rational use of collective resources.

Author Biographies

Tayane Vasconcellos Pereira, Universidade Federal do Estado do Rio de Janeiro (UNIRIO)

Graduanda em Medicina pela Universidade Federal do Estado do Rio de Janeiro, UNIRIO – RJ

Ana Luiza Ferreira Sales, Hospital Pró-Cardíaco

Cardiologista
Doutorado pela Universidade do Estado do Rio de Janeiro, RJ
Coordenadora do programa de Transplante Cardíaco e Suporte Circulatório Mecânico do Hospital Pró-Cardíaco, RJ
Coordenadora do Bloco Cirúrgico do Hospital Pró-Cardíaco, RJ

Lígia Neres Matos, Hospital Pró-Cardíaco

Enfermeira
Mestre pela Universidade Federal do Rio de Janeiro – UFRJ, RJ
Membro do International Consortium of Circulatory Assist Clinicians (ICCAC)
Enfermeira do Programa de Transplante Cardíaco e Suporte Circulatório Mecânico do Hospital Pró-Cardíaco, RJ

Alexandre Siciliano Colafranceschi, Universidade Federal do Estado do Rio de Janeiro (UNIRIO)

Cirurgião Torácico e Cardiovascular
Fellowship pela The Cleveland Clinic Foundation, OH – EUA
Mestrado pela Universidade de Harvard, MA – EUA
Doutorado pela Universidade de São Paulo, SP
Professor Adjunto da Universidade Federal do Estado do Rio de Janeiro, UNIRIO – RJ

References

Griepp RB, Ergin MA. The history of experimental heart transplantation. J Heart Transplant. 1984. 3:145.

Khush KK, Hsich E, Potena L, Cherikh WS, Chambers DC, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021 Oct. 40 (10):1035-1049.

Freitas NCC, Cherchiglia ML, Simão Filho C, Alvares-Teodoro J, Acurcio FA, Guerra Junior AA. Sixteen Years of Heart Transplant in an Open Cohort in Brazil: Analysis of Graft Survival of Patients using Immunosuppressants. Arq. Bras. Cardiol. 2021;116(4):744-53.

Avila MS, Belfort DSP. Progress in Heart Transplantation in Brazil: is it Time to Build a National Database?. Arq. Bras. Cardiol. 2021;116(4):754-5.

https://site.abto.org.br/en/publicacao/rbt-2019-2/. [Acessado 4 Julho 2022].

Bacal, Fernando et al. 3ª Diretriz Brasileira de Transplante Cardíaco. Arquivos Brasileiros de Cardiologia 2018 (111);2:230-289.

Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 2016; 35:1.

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62:e147.

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37:2129.

Lawton J, Tamis-Holland J, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. J Am Coll Cardiol. 2022 Jan, 79 (2) e21–e129.

Narula J, Bennett LE, DiSalvo T, Hosenpud JD, Semigran MJ, Dec GW. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation. 1997;63(6):861-7.

Ruderman I, Sevastos J, Anthony C, Ruygrok P, Chan W, Javorsky G, et al. Outcomes of simultaneous heart-kidney and lung-kidney transplantations: the Australian and New Zealand experience. Intern Med J. 2015;45(12):1236-41.

Atik, Fernando Antibas et al. Combined Heart and Kidney Transplantation: Initial Clinical Experience. Brazilian Journal of Cardiovascular Surgery. 2022, (37); 02: 263-267.

Russo MJ, Rana A, Chen JM, Hong KN, Gelijns A, Moskowitz A, et al. Pretransplantation patient characteristics and survival following combined heart and kidney transplantation: an analysis of the United Network for Organ Sharing Database. Arch Surg. 2009;144(3):241-6.

Smilowitz NR, Guo Y, Rao S, et al. Perioperativecardiovascular outcomes of non-cardiac solid organ transplant surgery. Eur Heart J Qual Care Clin Out-comes. 2019;5:72–78.

McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–2804.

Bailey CP, May A, Lemmon WM. Survival after coronary endarterectomy in man. J Am Med Assoc 164, 641-646 (1957).

Christenson JT, Simonet F, Schmuziger M. Extensive endarterectomy of the left anterior descending coronary artery combined with coronary artery bypass grafting. Coron Artery Dis 1995;6:731-7.

Halim MA, Qureshi SA, Towers MK, Yacoub MH. Early and late results of combined endarterectomy and coronary bypass grafting for diffuse coronary disease. Am J Cardiol 1982;49:1623-6.

Gao G, Zheng Z, Pi Y, Lu B, Lu J, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol 2010;56:1639-43.

Livesay JJ, Cooley DA, Hallman GL, Reul GJ, Ott DA, et al. Early and late results of coronary endarterectomy. Analysis of 3,369 patients. J Thorac Cardiovasc Surg 1986;92:649-60.

Nishigawa et al. JTCVS Techniques C 2021;133-137.

Radhakrishnan et al. Vessel Plus 2019; 3:36.

Published

2022-11-21

Issue

Section

Case Report